Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cybin Inc (NY: CYBN ) 0.3034 -0.0116 (-3.68%) Streaming Delayed Price Updated: 1:41 PM EDT, Jul 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Cybin Inc < Previous 1 2 3 4 5 6 7 8 9 ... 20 21 Next > Psychedelic Stock Gainers And Losers From February 23, 2023 February 23, 2023 Via Benzinga Cybin Stock Down On Laying Off 15% Of Workforce As Part Of A Streamlining Clinical Alignment February 23, 2023 Cybin Inc. (NEO:CYBN) (AMEX:CYBN) announced Thursday a streamlining plan aimed at maximizing the company’s operating efficiency and allowing it to focus on critical clinical trials. Via Benzinga Psychedelic Stock Gainers And Losers From February 22, 2023 February 22, 2023 Via Benzinga Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More February 21, 2023 Psychedelics States Reform: Utah, Iowa, Missouri and Oklahoma’s New Bills; Hawaii, Arizona and Washington's Green Lights, New Hampshire's Setback Earlier this week, three bills were introduced and... Via Benzinga Psychedelic Stock Gainers And Losers From February 21, 2023 February 21, 2023 Via Benzinga Psychedelic Stock Gainers And Losers From February 20, 2023 February 20, 2023 Via Benzinga "Multi-Bagger" Portfolio Outperforming "Rags-To-Riches" Portfolio YTD By A 2-To-1 Margin February 19, 2023 Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022. Perhaps some will bounce back with Via Talk Markets 6 Largest Psychedelic Stocks Showing Strength; Up 11.5% YTD February 17, 2023 A look at the performance of the six largest psychedelic stocks by market capitalization. Via Talk Markets ATAI Life Sciences, GH Research Among Top Psychedelic Movers Of Today February 17, 2023 Via Benzinga Cybin, Compass Pathways Among Top Psychedelic Movers Of Today February 16, 2023 Via Benzinga Psychedelic Stock Gainers And Losers From February 15, 2023 February 15, 2023 Via Benzinga GH Research, Mind Medicine Among Top Psychedelic Movers Of Today February 14, 2023 Via Benzinga Cybin Reports Q3 Earnings, Says Psilocybin Tial Is Progressing As MDD Treatment February 14, 2023 Cybin Inc. (NYSE: CYBN) has shared its unaudited financial results for the third quarter that ended Dec. 31, 2022. The company held total cash of $16.9 (CA$22.5) million as of Dec. 31, 2022, and $15... Via Benzinga Mind Medicine, GH Research Among Top Psychedelic Movers Of Today February 13, 2023 Via Benzinga "Multi-Bagger" Portfolio Update February 12, 2023 Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022. I'm tracking 12 microcap stocks that might bounce back with major returns - dare I say Via Talk Markets Major Psychedelic Compound-Based Stocks UP 13% YTD February 11, 2023 We track the performance of the 6 largest companies researching the treatment of mental illnesses based on the use of one or more of 10 different psychedelic compound-based substances. Via Talk Markets Cybin, Seelos Therapeutics Among Top Psychedelic Movers Of Today February 10, 2023 Via Benzinga Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today February 09, 2023 Via Benzinga Psychedelic Stock Gainers And Losers From February 8, 2023 February 08, 2023 Via Benzinga Psychedelic Stock Gainers And Losers From February 7, 2023 February 07, 2023 Via Benzinga The "Multi-Bagger" Portfolio Continued To Outperform The S&P 500 Last Week February 06, 2023 Our basket of mostly microcap cannabis, psychedelic and plant-based food stocks was extremely oversold in 2022 but we're watching for them to bounce back in 2023. Via Talk Markets Mind Medicine, GH Research Among Top Psychedelic Movers Of Today February 06, 2023 Via Benzinga The 7 Most Promising Psychedelic Stocks to Buy in February February 05, 2023 These psychedelics stocks to buy belong to pre-revenue firms which could potentially blow-up in line with the burgeoning sector. Via InvestorPlace 6 Largest Psychedelic Stocks Down 3% This Week February 04, 2023 The six largest of the 40 companies researching the treatment of mental illnesses by using psychedelic substances, which constitute our Psychedelic Drug Stocks Index, are now up 13% YTD despite a loss... Via Talk Markets Psychedelic Stock Gainers And Losers From February 3, 2023 February 03, 2023 Via Benzinga Psychedelic Stock Gainers And Losers From February 2, 2023 February 02, 2023 Via Benzinga Psychedelic Stock Gainers And Losers From February 1, 2023 February 01, 2023 Via Benzinga Cybin Approved For First In-Human Dosing Of DMT Molecule CYB004, Milestone For Anxiety Disorder Treatment February 01, 2023 Cybin Inc. (NYSE: CYBN) announced that it has received approval from an independent ethics committee in the Netherlands to begin the first in-human dosing of its proprietary deuterated... Via Benzinga GH Research, Mind Medicine Among Top Psychedelic Movers Of Today January 31, 2023 Via Benzinga Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today January 30, 2023 Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 20 21 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.